文献速递消化道肿瘤放疗放疗物理与技术

胰腺癌立体定向体部放疗联合序贯化疗作为初始治疗后的局部失败模式:靶区设计的意义

Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume Design.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2019-01-23

本研究回顾性分析了510例接受立体定向体部放疗联合化疗作为初始治疗的胰腺癌患者的局部失败模式。结果显示腹腔干、肠系膜上动脉和腹膜后区域是局部复发的高危区域,且BED10<60 Gy与更差的生存相关。作者认为可能需要从大体肿瘤体积进行非均匀且充分的扩边,并至少达到BED10≥60 Gy以改善预后。

要点

  • 腹腔干、肠系膜上动脉和腹膜后区域是胰腺癌立体定向体部放疗后局部复发的高危区域。
  • 多因素分析显示腹腔干和肠系膜上动脉同时复发、肝门复发、CA19-9无反应及BED10<60 Gy预测更差生存。
  • 作者认为可能需要从大体肿瘤体积进行非均匀且充分的扩边,并至少达到BED10≥60 Gy。

核心结论

  • 靠近腹腔干、肠系膜上动脉和腹膜后间隙的区域是局部复发的高危区域。
  • 作者认为可能需要从大体肿瘤体积进行非均匀且充分的扩边,邻近肿瘤的脾血管也可能被纳入靶区而不影响危及器官的剂量约束。
  • 作者认为至少需要BED10≥60 Gy才能获得更好的结局。

研究设计与样本

  • 回顾性分析连续纳入的可切除或交界可切除但因合并症无法手术的胰腺癌患者及局部晚期胰腺癌患者,均接受立体定向体部放疗联合化疗作为初始治疗。
  • 共纳入510例患者,局部复发相对于腹腔干、肠系膜上动脉和脾动脉的位置被绘制在一张模板患者的CT扫描上。

主要发现

  • 全组中位随访时间为21.8个月(范围3.1-54.9个月)。
  • 217例患者出现局部区域复发,293例患者发现局部和远处进展。
  • 169例(33.2%)和144例(28.2%)患者复发分别更靠近腹腔干和肠系膜上动脉,115例(22.5%)患者同时发现腹腔干和肠系膜上动脉侵犯。
  • 33例(6.5%)和49例(9.6%)患者分别在肝门和脾动脉处复发,138例(27.1%)患者还出现腹膜后进展。
  • 至腹腔干、肠系膜上动脉和腹膜后复发的平均距离分别为9.0 mm、8.3 mm和11.7 mm。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To identify patterns of local failure in patients with pancreatic cancer receiving stereotactic body radiation therapy plus chemotherapy as initial treatment, for the optimal design of target volumes encompassing a majority of local recurrences. METHODS AND MATERIALS: Consecutive patients with resectable or borderline resectable but medically inoperable cancer owing to comorbidities and locally advanced pancreatic cancer undergoing stereotactic body radiation therapy and chemotherapy were reviewed. Local recurrences were plotted with respect to the celiac trunk (CT), superior mesenteric artery (SMA), and splenic artery on 1 computed tomographic scan of a template patient. RESULTS: Five hundred and ten patients were included. Median follow-up of the entire group was 21.8 months (range, 3.1-54.9 months). Two hundred and seventeen patients had locoregional recurrences, whereas local and distant progressions were found in 293 patients. One hundred and sixty-nine (33.2%) and 144 (28.2%) patients had recurrences closer to the CT and SMA, respectively, whereas both invasions of the CT and SMA were found in 115 patients (22.5%). In addition, 33 patients (6.5%) and 49 patients (9.6%) had recurrences at the hepatic hilum and the splenic artery, respectively. Besides these patterns of failure, 138 patients (27.1%) also experienced retroperitoneal progressions. The mean distance to the CT, SMA, and retroperitoneal recurrence was 9.0, 8.3, and 11.7 mm, respectively. Multivariable analysis demonstrated that advanced pancreatic cancer, recurrences at both the CT and SMA and the hepatic hilum, CA19-9 nonresponders, and BED10 <60 Gy were predictive of worse survival. CONCLUSIONS: Areas closer to the CT, SMA, and retroperitoneal space were at a high risk of local recurrences. Nonuniform and sufficient expansions from the gross tumor volume might be necessary, and the splenic vessels abutting the tumor might also be included in the target volume without compromise of dose constraints of organs at risk. In addition, at least BED10 ≥60 Gy might be required to achieve better outcomes.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Zhu X, Ju X, Cao Y, et al. Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume Design. Int J Radiat Oncol Biol Phys. 2019. PMID: 30684663. doi:10.1016/j.ijrobp.2019.01.075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。